These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 29300993)

  • 1. The Existing Drug Vorinostat as a New Lead Against Cryptosporidiosis by Targeting the Parasite Histone Deacetylases.
    Guo F; Zhang H; McNair NN; Mead JR; Zhu G
    J Infect Dis; 2018 Mar; 217(7):1110-1117. PubMed ID: 29300993
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost-effective In Vivo and In Vitro Mouse Models for Evaluating Anticryptosporidial Drug Efficacy: Assessing Vorinostat, Docetaxel, and Baicalein.
    Liu M; Zhang D; Wang D; Wu X; Zhang Y; Yin J; Zhu G
    J Infect Dis; 2023 Nov; 228(10):1430-1440. PubMed ID: 37418629
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A high-throughput phenotypic screen identifies clofazimine as a potential treatment for cryptosporidiosis.
    Love MS; Beasley FC; Jumani RS; Wright TM; Chatterjee AK; Huston CD; Schultz PG; McNamara CW
    PLoS Negl Trop Dis; 2017 Feb; 11(2):e0005373. PubMed ID: 28158186
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Novel Piperazine-Based Drug Lead for Cryptosporidiosis from the Medicines for Malaria Venture Open-Access Malaria Box.
    Jumani RS; Bessoff K; Love MS; Miller P; Stebbins EE; Teixeira JE; Campbell MA; Meyers MJ; Zambriski JA; Nunez V; Woods AK; McNamara CW; Huston CD
    Antimicrob Agents Chemother; 2018 Apr; 62(4):. PubMed ID: 29339392
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of chitosan, a natural polysaccharide, against Cryptosporidium parvum in vitro and in vivo in neonatal mice.
    Mammeri M; Chevillot A; Thomas M; Polack B; Julien C; Marden JP; Auclair E; Vallée I; Adjou KT
    Exp Parasitol; 2018 Nov; 194():1-8. PubMed ID: 30237052
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 5-Aminopyrazole-4-Carboxamide-Based Compounds Prevent the Growth of Cryptosporidium parvum.
    Huang W; Choi R; Hulverson MA; Zhang Z; McCloskey MC; Schaefer DA; Whitman GR; Barrett LK; Vidadala RSR; Riggs MW; Maly DJ; Van Voorhis WC; Ojo KK; Fan E
    Antimicrob Agents Chemother; 2017 Aug; 61(8):. PubMed ID: 28533246
    [No Abstract]   [Full Text] [Related]  

  • 7. A cysteine protease inhibitor rescues mice from a lethal Cryptosporidium parvum infection.
    Ndao M; Nath-Chowdhury M; Sajid M; Marcus V; Mashiyama ST; Sakanari J; Chow E; Mackey Z; Land KM; Jacobson MP; Kalyanaraman C; McKerrow JH; Arrowood MJ; Caffrey CR
    Antimicrob Agents Chemother; 2013 Dec; 57(12):6063-73. PubMed ID: 24060869
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel calcium-dependent protein kinase inhibitor as a lead compound for treating cryptosporidiosis.
    Castellanos-Gonzalez A; White AC; Ojo KK; Vidadala RS; Zhang Z; Reid MC; Fox AM; Keyloun KR; Rivas K; Irani A; Dann SM; Fan E; Maly DJ; Van Voorhis WC
    J Infect Dis; 2013 Oct; 208(8):1342-8. PubMed ID: 23878324
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tyrosine Kinase Inhibitors Display Potent Activity against Cryptosporidium parvum.
    Nava MG; Calderón F; Fernández E; Ballell L; Bamborough P; Vinayak S
    Microbiol Spectr; 2023 Feb; 11(1):e0387422. PubMed ID: 36533912
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bobel-24 activity against Cryptosporidium parvum in cell culture and in a SCID mouse model.
    Rueda C; Fenoy S; Simón F; Del Aguila C
    Antimicrob Agents Chemother; 2008 Mar; 52(3):1150-2. PubMed ID: 18160525
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Novel Calcium-Dependent Kinase Inhibitor, Bumped Kinase Inhibitor 1517, Cures Cryptosporidiosis in Immunosuppressed Mice.
    Castellanos-Gonzalez A; Sparks H; Nava S; Huang W; Zhang Z; Rivas K; Hulverson MA; Barrett LK; Ojo KK; Fan E; Van Voorhis WC; White AC
    J Infect Dis; 2016 Dec; 214(12):1850-1855. PubMed ID: 27738055
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optimization of Methionyl tRNA-Synthetase Inhibitors for Treatment of
    Buckner FS; Ranade RM; Gillespie JR; Shibata S; Hulverson MA; Zhang Z; Huang W; Choi R; Verlinde CLMJ; Hol WGJ; Ochida A; Akao Y; Choy RKM; Van Voorhis WC; Arnold SLM; Jumani RS; Huston CD; Fan E
    Antimicrob Agents Chemother; 2019 Apr; 63(4):. PubMed ID: 30745384
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vorinostat as potential antiparasitic drug.
    Herrera-Martínez M; Orozco-Samperio E; Montaño S; Ariza-Ortega JA; Flores-García Y; López-Contreras L
    Eur Rev Med Pharmacol Sci; 2020 Jul; 24(13):7412-7419. PubMed ID: 32706080
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel lactate dehydrogenase inhibitors with in vivo efficacy against Cryptosporidium parvum.
    Li K; Nader SM; Zhang X; Ray BC; Kim CY; Das A; Witola WH
    PLoS Pathog; 2019 Jul; 15(7):e1007953. PubMed ID: 31356619
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amelioration of Cryptosporidium parvum infection in vitro and in vivo by targeting parasite fatty acyl-coenzyme A synthetases.
    Guo F; Zhang H; Fritzler JM; Rider SD; Xiang L; McNair NN; Mead JR; Zhu G
    J Infect Dis; 2014 Apr; 209(8):1279-87. PubMed ID: 24273180
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amixicile Reduces Severity of Cryptosporidiosis but Does Not Have
    Bartelt LA; Bolick DT; Kolling GL; Stebbins E; Huston CD; Guerrant RL; Hoffman PS
    Antimicrob Agents Chemother; 2018 Dec; 62(12):. PubMed ID: 30297368
    [No Abstract]   [Full Text] [Related]  

  • 17. Vorinostat, a histone deacetylase inhibitor, as a potential novel treatment for psoriasis.
    Samuelov L; Bochner R; Magal L; Malovitski K; Sagiv N; Nousbeck J; Keren A; Fuchs-Telem D; Sarig O; Gilhar A; Sprecher E
    Exp Dermatol; 2022 Apr; 31(4):567-576. PubMed ID: 34787924
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Validation of IMP dehydrogenase inhibitors in a mouse model of cryptosporidiosis.
    Gorla SK; McNair NN; Yang G; Gao S; Hu M; Jala VR; Haribabu B; Striepen B; Cuny GD; Mead JR; Hedstrom L
    Antimicrob Agents Chemother; 2014; 58(3):1603-14. PubMed ID: 24366728
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activities of DL-alpha-difluoromethylarginine and polyamine analogues against Cryptosporidium parvum infection in a T-cell receptor alpha-deficient mouse model.
    Yarlett N; Waters WR; Harp JA; Wannemuehler MJ; Morada M; Bellcastro J; Upton SJ; Marton LJ; Frydman BJ
    Antimicrob Agents Chemother; 2007 Apr; 51(4):1234-9. PubMed ID: 17242149
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of pyrvinium pamoate against Cryptosporidium parvum infection in vitro and in a neonatal mouse model.
    Downey AS; Chong CR; Graczyk TK; Sullivan DJ
    Antimicrob Agents Chemother; 2008 Sep; 52(9):3106-12. PubMed ID: 18591280
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.